The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Updated: ART Drug-Drug Interactions Guide (2/26/21)
- Medscape Commentary: The Vanguard of HIV Care: Don't Forget This Screening (2/23/21)
- Topics, Trends & Updates (2/11/21)
- New Guideline: Comprehensive Primary Care for Adults With HIV (2/9/21)
- Remembering Dr. John G. Bartlett (1/25/21)
- Guidance: Adolescent Consent to HIV and STI Treatment and Prevention (1/6/21)
- New Guideline: Substance Use Screening and Risk Assessment in Adults (10/21/20)
- Diagnosis and Management of HIV-2 in Adults Updated (10/5/20)
- CDC: COVID-19 and HIV
- Medical Care Criteria Committee Advocates COVID-19 Vaccine Priority Status for People With HIV (1/12/21)
- Guidance: Opioid Use Disorder Treatment During COVID-19 (1/4/21)
- Guidance: Strategies for STI Screening and Treatment During COVID-19 (11/5/2020)
- Guidance: Rapid ART Initiation During COVID-19 (8/26/20)
- HHS Adults and Adolescents Antiretroviral Guidelines Panel Recommendation for the Long-Acting Injectable Antiretroviral Regimen of Cabotegravir and Rilpivirine (2/24/21)
- CEI Newsletter (2/23/21)
- NYSDOH Health Advisory: Gonorrhea Increases In New York State Counties Outside of New Yok City (2/10/21)
- AETC NCRC: Updates from Program Friends & Colleagues (2/9/21)
- NYS Medicaid Update: January 2021 (2/3/21)
- FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV (1/22/21)
- DHHS Interim Guidance for COVID-19 and Persons with HIV (3/1/2021)
- NYCDOHMH: Dear Colleague Best Practices for Reporting Race, Ethnicity Data for COVID-19 Tests, Vaccinations (2/17/21)
- NYC DOHMH: Dear Colleague COVID-19 Updates, Behavioral Health and Suicide Prevention During COVID-19 (1/20/21)
- NYCDOHMH: Dear Colleague Clinical considerations for Moderna COVID-19 vaccine (12/28/20)
- NYCDOHMH: Dear Colleague Allocation of Limited COVID-19 Vaccine (12/24/20)
- NYCDOHMH: Dear Colleague Clinical considerations for Pfizer-BioNtech COVID-19 vaccine (12/17/20)